{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:42:13Z","timestamp":1792791733301,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.crad.2026.107460","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:12:22Z","timestamp":1787181142000},"page":"107460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["State of the art imaging in ovarian carcinomatosis: how the radiologist can help plan management"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4873-396X","authenticated-orcid":false,"given":"C.","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-6816","authenticated-orcid":false,"given":"S.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-1480","authenticated-orcid":false,"given":"N.","family":"Bharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8270-5597","authenticated-orcid":false,"given":"A.G.","family":"Rockall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.crad.2026.107460_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121957","article-title":"Ovarian cancer dissemination-A cell biologist's perspective","volume":"11","author":"Farsinejad","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2026.107460_bib3","series-title":"e","article-title":"WHO classification. PathologyOutlines.com websit","author":"Adhikari","year":"2026"},{"key":"10.1016\/j.crad.2026.107460_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejogrb.2024.06.025","article-title":"British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: recommendations for practice update 2024","volume":"300","author":"Moss","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"S1","key":"10.1016\/j.crad.2026.107460_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijgo.70282","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2025 update","volume":"171","author":"Renz","year":"2025","journal-title":"Int J Gynecol Obstet"},{"issue":"9","key":"10.1016\/j.crad.2026.107460_bib6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crad.2026.107460_bib7","doi-asserted-by":"crossref","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol.20(5):1248\u20131259.","DOI":"10.1200\/JCO.2002.20.5.1248"},{"issue":"6","key":"10.1016\/j.crad.2026.107460_bib8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO\u2013ESMO\u2013ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease\u2606","volume":"35","author":"Ledermann","year":"2024","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib13","first-page":"42","article-title":"Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies","volume":"7","author":"Kaijser","year":"2015","journal-title":"Facts Views Vis Obgyn"},{"issue":"10","key":"10.1016\/j.crad.2026.107460_bib14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S1470-2045(24)00406-6","article-title":"Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study","volume":"25","author":"Sundar","year":"2024","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1148\/radiol.13121161","article-title":"Adnexal masses: development and preliminary validation of an MR imaging scoring system","volume":"267","author":"Thomassin-Naggara","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19896","article-title":"Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses","volume":"3","author":"Thomassin-Naggara","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiol.2232011081","article-title":"Peritoneal metastases: detection with spiral CT in patients with ovarian cancer","volume":"223","author":"Coakley","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2026.107460_bib18","article-title":"Diffusion-weighted magnetic resonance imaging in peritoneal carcinomatosis from suspected ovarian cancer: diagnostic performance in correlation with surgical findings","volume":"121","author":"Garcia","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.crad.2026.107460_bib19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejrad.2019.03.007","article-title":"MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients","volume":"114","author":"Engbersen","year":"2019","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.crad.2026.107460_bib20","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1007\/s00330-024-11300-7","article-title":"Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group","volume":"35","author":"Rizzo","year":"2025","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol."},{"issue":"8","key":"10.1016\/j.crad.2026.107460_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081044","article-title":"Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: a review of the literature","volume":"11","author":"Thomakos","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.crad.2026.107460_bib23","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s00261-015-0429-5","article-title":"The subperitoneal space and peritoneal cavity: basic concepts","volume":"40","author":"Pannu","year":"2015","journal-title":"Abdom Imaging"},{"issue":"4","key":"10.1016\/j.crad.2026.107460_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","article-title":"Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles","volume":"43","author":"Yousefi","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2214\/AJR.20.22997","article-title":"Understanding the lymphatics: an updated review of the N category of the AJCC 8th edition for urogenital cancers","volume":"217","author":"Pedersen","year":"2021","journal-title":"Am J Roentgenol"},{"issue":"17_suppl","key":"10.1016\/j.crad.2026.107460_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA5505","article-title":"Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: the CARACO phase III randomized trial","volume":"42","author":"Classe","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.crad.2026.107460_bib27","article-title":"Preoperative CT or PET\/CT to assess pelvic and para-aortic lymph node status in epithelial ovarian cancer? A systematic review and meta-analysis","volume":"11","author":"Mimoun","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.crad.2026.107460_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.semnuclmed.2019.06.010","article-title":"PET\/CT for evaluation of ovarian cancer","volume":"49","author":"Kemppainen","year":"2019","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ygyno.2009.12.008","article-title":"Does the use of diagnostic PET\/CT cause stage migration in patients with primary advanced ovarian cancer?","volume":"116","author":"Risum","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2013.09.024","article-title":"Preoperative 18F-FDG PET\/CT in the management of advanced epithelial ovarian cancer","volume":"131","author":"Fruscio","year":"2013","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.crad.2026.107460_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejogrb.2024.02.028","article-title":"Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?","volume":"296","author":"Braun","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.crad.2026.107460_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1245\/s10434-020-08649-6","article-title":"The peritoneal cancer index is a strong predictor of incomplete cytoreductive surgery in ovarian cancer","volume":"28","author":"J\u00f3nsd\u00f3ttir","year":"2021","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"10.1016\/j.crad.2026.107460_bib34","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/ijgc-2022-004093","article-title":"The peritoneal cancer index as a predictor of complete cytoreduction at primary and interval cytoreductive surgery in advanced ovarian cancer","volume":"33","author":"Fagan","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.crad.2026.107460_bib35","first-page":"2024","article-title":"Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer?: a systematic review and meta-analysis based on the latest evidence","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.crad.2026.107460_bib36","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13048-020-00625-8","article-title":"Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters","volume":"13","author":"Sartor","year":"2020","journal-title":"J Ovarian Res"},{"issue":"4","key":"10.1016\/j.crad.2026.107460_bib38","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.3802\/jgo.2018.29.e47","article-title":"Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study","volume":"29","author":"Elzarkaa","year":"2018","journal-title":"J Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.crad.2026.107460_bib39","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11547-020-01170-6","article-title":"Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival","volume":"125","author":"Avesani","year":"2020","journal-title":"Radiol Med"},{"issue":"8","key":"10.1016\/j.crad.2026.107460_bib40","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.ejso.2021.03.239","article-title":"Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET\/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer","volume":"47","author":"Mikkelsen","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.crad.2026.107460_bib41","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s00330-024-11124-5","article-title":"Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM","volume":"35","author":"Vandecaveye","year":"2025","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.crad.2026.107460_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081467","article-title":"Imaging of peritoneal metastases in ovarian cancer using MDCT, MRI, and FDG PET\/CT: a systematic review and meta-analysis","volume":"16","author":"Tsili","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2017.06.008","article-title":"Impact of ascites volume on clinical outcomes in ovarian cancer: a cohort study","volume":"146","author":"Szender","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1102\/1470-7330.2007.0030","article-title":"Cytoreductive surgery in ovarian cancer","volume":"7","author":"Pomel","year":"2007","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.crad.2026.107460_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102945","article-title":"Optimal bevacizumab treatment strategy in advanced ovarian cancer: a review","volume":"137","author":"Monk","year":"2025","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4251\/wjgo.v2.i1.31","article-title":"Selection of patients and staging of peritoneal surface malignancies","volume":"2","author":"Cotte","year":"2010","journal-title":"World J Gastrointest Oncol"},{"issue":"23","key":"10.1016\/j.crad.2026.107460_bib48","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.3390\/cancers14236010","article-title":"Cytoreductive surgery (CRS) and HIPEC for advanced ovarian cancer with peritoneal metastases: italian PSM oncoteam evidence and study purposes","volume":"14","author":"Marrelli","year":"2022","journal-title":"Cancers."},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.crad.2026.107460_bib51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3802\/jgo.2015.26.4.336","article-title":"Role of aggressive surgical cytoreduction in advanced ovarian cancer","volume":"26","author":"Chang","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.crad.2026.107460_bib52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12885-015-1525-1","article-title":"Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study","volume":"15","author":"Ren","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/std12010001","article-title":"Upper-abdominal cytoreduction for advanced ovarian cancer\u2014therapeutic rationale, surgical anatomy and techniques of cytoreduction","volume":"12","author":"Bhandoria","year":"2023","journal-title":"Surg Tech Dev"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1148\/radiol.2482070371","article-title":"Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion","volume":"248","author":"Akin","year":"2008","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020285","article-title":"Neglected anatomical areas in ovarian cancer: significance for optimal debulking surgery","volume":"16","author":"Kostov","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1245\/s10434-020-08989-3","article-title":"Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction","volume":"28","author":"Di Donato","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21037\/hbsn.2018.12.06","article-title":"Surgical treatment of ovarian cancer liver metastasis","volume":"8","author":"Wang","year":"2018","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygyno.2016.08.232","article-title":"Porta hepatis peritonectomy and hepato-celiac lymphadenectomy in patients with stage IIIC-IV ovarian cancer: diagnostic pathway, surgical technique and outcomes","volume":"143","author":"Tozzi","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib59","first-page":"174","article-title":"Cooccurrence of capsular liver lesions along with peritoneal carcinomatosis and hematogenous metastases in ovarian cancer patients on consecutive (18)F-FDG PET\/CT studies","volume":"33","author":"\u00dcnal","year":"2024","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib60","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3802\/jgo.2024.35.e25","article-title":"Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer","volume":"35","author":"Chen","year":"2024","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/IGC.0000000000001180","article-title":"Metastatic involvement of lesser sac in advanced epithelial ovarian cancer","volume":"28","author":"Mukhopadhyay","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.crad.2026.107460_bib62","doi-asserted-by":"crossref","DOI":"10.21037\/gpm-21-3","article-title":"The principles of safe and efficacious upper abdominal surgery","volume":"4","author":"Fotopoulou","year":"2021","journal-title":"Gynecol Pelvic Med"},{"issue":"6","key":"10.1016\/j.crad.2026.107460_bib63","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.3802\/jgo.2016.27.e62","article-title":"Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer","volume":"27","author":"Xiang","year":"2016","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib64","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.3802\/jgo.2022.33.e30","article-title":"Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer","volume":"33","author":"Nishikimi","year":"2022","journal-title":"J Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.crad.2026.107460_bib65","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ijgc-2021-002951","article-title":"European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery","volume":"31","author":"Fotopoulou","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12957-020-01841-8","article-title":"Metastasis to para-aortic lymph nodes cephalad to the renal veins in patients with ovarian cancer","volume":"18","author":"Komiyama","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/ijgc-2023-004963","article-title":"Cardiophrenic lymph nodes in advanced ovarian cancer","volume":"34","author":"Agusti","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.crad.2026.107460_bib68","first-page":"2024","article-title":"Survival impact and safety of intrathoracic and abdominopelvic cytoreductive surgery in advanced ovarian cancer: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.crad.2026.107460_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16233985","article-title":"Anatomy, imaging, and surgical treatment of thoracic lymphadenopathies in advanced epithelial ovarian cancer","volume":"16","author":"Rizzo","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/pp-2020-0152","article-title":"Prevalence, clinical characteristics, and outcome of pleural effusions in ovarian cancer","volume":"6","author":"Porcel","year":"2021","journal-title":"Pleura Peritoneum"},{"issue":"6","key":"10.1016\/j.crad.2026.107460_bib71","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.crad.2018.02.001","article-title":"What the radiologist should know about postoperative MDCT evaluation of a patient treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy","volume":"73","author":"Durot","year":"2018","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.crad.2026.107460_bib72","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1148\/rg.294085223","article-title":"Fistulas in malignant gynecologic disease: etiology, imaging, and management","volume":"29","author":"Narayanan","year":"2009","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2026.107460_bib73","series-title":"Recommendations for cross-sectional imaging in cancer management","first-page":"18","year":"2022"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib75","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2016.08.322","article-title":"Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: a retrospective evaluation","volume":"143","author":"Nasser","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2026.107460_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1060006","article-title":"Predicting incomplete cytoreduction in patients with advanced ovarian cancer","volume":"12","author":"Egger","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.crad.2026.107460_bib77","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/uog.23654","article-title":"Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study)","volume":"59","author":"Fischerova","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.crad.2026.107460_bib78","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/IGC.0b013e3181a84595","article-title":"Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion","volume":"19","author":"Cohen-Mouly","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.crad.2026.107460_bib79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejogrb.2018.05.024","article-title":"Diaphragm disease in advanced ovarian cancer: predictability of pre-operative imaging and safety of surgical intervention","volume":"226","author":"Pounds","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.31083\/j.ejgo.2020.01.5032","article-title":"Correlation of diaphragm surgical findings with preoperative","volume":"41","author":"Pereira","year":"2020","journal-title":"Eur J Gynaecol Oncol"},{"issue":"10","key":"10.1016\/j.crad.2026.107460_bib81","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.diii.2022.05.003","article-title":"The BUMPy road of peritoneal metastases in ovarian cancer","volume":"103","author":"Nougaret","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.crad.2026.107460_bib82","article-title":"Evaluating the tozzi classification system in diaphragm surgeries for advanced ovarian cancer: clinical applicability and perioperative outcomes","volume":"44","author":"Vuppu","year":"2025","journal-title":"Cancer Treat Res Commun"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib83","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1148\/radiol.12110872","article-title":"Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging\u2014initial experience","volume":"263","author":"Coolen","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ygyno.2016.04.018","article-title":"A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies","volume":"142","author":"Fehniger","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.crad.2026.107460_bib85","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1007\/s00330-021-08013-6","article-title":"Diffusion-weighted imaging diagnostic algorithm in patients with suspected pleural malignancy","volume":"31","author":"Jiang","year":"2021","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib86","doi-asserted-by":"crossref","first-page":"117.e1","DOI":"10.1016\/j.ajog.2024.02.302","article-title":"A modified diffusion-weighted magnetic resonance imaging-based model from the radiologist's perspective: improved performance in determining the surgical resectability of advanced high-grade serous ovarian cancer","volume":"231","author":"Lu","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.crad.2026.107460_bib87","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3348\/kjr.2025.0357","article-title":"CT and MRI in advanced ovarian cancer: advances in imaging techniques","volume":"26","author":"Chiu","year":"2025","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.crad.2026.107460_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108786","article-title":"Pre-operative evaluation of epithelial ovarian cancer patients: role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study","volume":"123","author":"Rizzo","year":"2020","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.crad.2026.107460_bib89","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024251","article-title":"Diagnostic value of diffusion-weighted imaging\/magnetic resonance imaging for peritoneal metastasis from malignant tumor: a systematic review and meta-analysis","volume":"100","author":"Dong","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"1125","key":"10.1016\/j.crad.2026.107460_bib90","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210117","article-title":"The role of CT, PET-CT, and MRI in ovarian cancer","volume":"94","author":"Engbersen","year":"2021","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib91","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.crad.2010.09.018","article-title":"FDG PET\/CT features of ovarian metastasis","volume":"66","author":"Kitajima","year":"2011","journal-title":"Clin Radiol"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib92","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/IGC.0000000000000074","article-title":"Diagnostic value of preoperative SUVmax on FDG-PET\/CT for the detection of ovarian cancer","volume":"24","author":"Tanizaki","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.crad.2026.107460_bib93","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1007\/s00259-021-05450-9","volume":"48","author":"Delgado Bolton","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib94","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13048-020-00662-3","article-title":"Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers","volume":"13","author":"Tsoi","year":"2020","journal-title":"J Ovarian Res"},{"issue":"8","key":"10.1016\/j.crad.2026.107460_bib95","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.21037\/qims-20-784","article-title":"Diagnostic accuracy of (18)F-FDG PET\/CT scan for peritoneal metastases in advanced ovarian cancer","volume":"11","author":"Feng","year":"2021","journal-title":"Quant Imaging Med Surg"},{"issue":"11","key":"10.1016\/j.crad.2026.107460_bib96","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/aogs.14442","article-title":"Preoperative PET\/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers","volume":"101","author":"Wang","year":"2022","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"16","key":"10.1016\/j.crad.2026.107460_bib97","article-title":"Predicting complete cytoreduction with preoperative [(18)F]FDG PET\/CT in patients with ovarian cancer: a systematic review and meta-analysis","volume":"14","author":"Csikos","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"10.1016\/j.crad.2026.107460_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17040698","article-title":"Prognostic value of pretreatment (18)F-FDG-PET\/CT metabolic parameters in advanced high-grade serous ovarian cancer","volume":"17","author":"Travaglio Morales","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40644-021-00399-2","article-title":"Validation of 18F-FDG PET\/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study","volume":"21","author":"J\u00f3nsd\u00f3ttir","year":"2021","journal-title":"Cancer Imaging"},{"issue":"16","key":"10.1016\/j.crad.2026.107460_bib100","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.3390\/cancers17162612","article-title":"Evaluating the diagnostic performance of PET\/MR versus CECT in determining resectability in ovarian cancer","volume":"17","author":"Virarkar","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13550-020-00712-3","article-title":"Diagnostic value of [(18)F]FDG PET\/MRI for staging in patients with ovarian cancer","volume":"10","author":"Tsuyoshi","year":"2020","journal-title":"EJNMMI Res."},{"issue":"5","key":"10.1016\/j.crad.2026.107460_bib102","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3390\/cancers17050746","article-title":"Residual tumour at CT scan based on radiologic peritoneal carcinomatosis index after optimal cytoreduction in advanced ovarian cancer: a true prognostic factor","volume":"17","author":"Trelis","year":"2025","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.crad.2026.107460_bib103","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1007\/s00330-024-10674-y","article-title":"Prospective validation of the role of PET\/CT in detecting disease after neoadjuvant chemotherapy in advanced ovarian cancer","volume":"34","author":"Lee","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2026.107460_bib104","article-title":"Meta-analysis of the diagnostic value of (18)F-FDG PET\/CT in the recurrence of epithelial ovarian cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s43055-023-01067-0","article-title":"Efficiency of whole-body positron emission tomography\/computed tomography using 18F-Fluorodeoxyglucose in detecting the cause of elevated cancer antigen 125 serum level in treated ovarian cancer patients","volume":"54","author":"Ali","year":"2023","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4274\/mirt.galenos.2018.00710","article-title":"The role of (18)F-FDG PET\/CT in detecting ovarian cancer recurrence in patients with elevated CA-125 levels","volume":"28","author":"Cengiz","year":"2019","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib107","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13244-024-01855-w","article-title":"Intratumoral and peritumoral MRI-based radiomics for predicting extrapelvic peritoneal metastasis in epithelial ovarian cancer","volume":"15","author":"Wang","year":"2024","journal-title":"Insights Imaging"},{"issue":"5","key":"10.1016\/j.crad.2026.107460_bib108","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.acra.2023.11.032","article-title":"CT-Based radiomics for the preoperative prediction of occult peritoneal metastasis in epithelial ovarian cancers","volume":"31","author":"Li","year":"2024","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1016\/j.crad.2026.107460_bib109","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1007\/s00261-025-05162-w","article-title":"CT-Based radiomics and deep learning for the preoperative prediction of peritoneal metastasis in ovarian cancers","volume":"51","author":"Liu","year":"2026","journal-title":"Abdom Radiol"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63369-1","article-title":"Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer","volume":"14","author":"Leng","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.crad.2026.107460_bib111","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1016\/j.acra.2024.12.074","article-title":"A multimodal model based on transvaginal ultrasound-based radiomics to predict the risk of peritoneal metastasis in ovarian cancer: a multicenter study","volume":"32","author":"Zhou","year":"2025","journal-title":"Acad Radiol"},{"issue":"12","key":"10.1016\/j.crad.2026.107460_bib112","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45141","article-title":"Computed tomographic radiomics in differentiating histologic subtypes of epithelial ovarian carcinoma","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.crad.2026.107460_bib113","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-019-08718-9","article-title":"A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer","volume":"10","author":"Lu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.crad.2026.107460_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2025.106833","article-title":"Advancing personalised care in ovarian cancer using CT and MRI radiomics","volume":"84","author":"Chiu","year":"2025","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2026.107460_bib115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2024.10.003","article-title":"Prediction of non-resectability in tubo-ovarian cancer patients using Peritoneal Cancer Index - a prospective multicentric study using imaging (ISAAC study)","volume":"191","author":"Pinto","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.crad.2026.107460_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133179","article-title":"Prospective comparison of the performance of MRI versus CT in the detection and evaluation of peritoneal surface malignancies","volume":"14","author":"Chia","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.crad.2026.107460_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11030476","article-title":"CT enterography for preoperative evaluation of peritoneal carcinomatosis index in advanced ovarian cancer","volume":"11","author":"Delgado-Barriga","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.crad.2026.107460_bib118","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00404-022-06466-8","article-title":"The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC)","volume":"306","author":"Asp","year":"2022","journal-title":"Arch Gynecol Obstet"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:53Z","timestamp":1792790933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026002370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":114,"alternative-id":["S0009926026002370"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107460","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State of the art imaging in ovarian carcinomatosis: how the radiologist can help plan management","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107460"}}